Last reviewed · How we verify
Placebo for micronized progesterone — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for micronized progesterone (Placebo for micronized progesterone) — Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for micronized progesterone TARGET | Placebo for micronized progesterone | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for micronized progesterone CI watch — RSS
- Placebo for micronized progesterone CI watch — Atom
- Placebo for micronized progesterone CI watch — JSON
- Placebo for micronized progesterone alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for micronized progesterone — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-micronized-progesterone. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab